Dimension Inx, a spin-out from the Northwestern University, is a biofabrication startup that creates next-gen biomaterials and 3D-printed bioactive structures that enable organ and tissue regeneration and repair.
Dimension Inx is leading the way in the development of advanced 3D-printable materials and manufacturing processes, with application in medicine and beyond.
Dimension Inx was founded in 2017 by Caralynn Nowinski Collens, Ramille Shah and Adam Jakus. The company is headquartered in Chicago, Illinois.
Dimension Inx has developed a biofabrication process, with patented materials design and manufacturing platform, that creates 3D printed implants for human tissue repair and regeneration.
Dimension Inx's technology platform overcomes existing challenges in biomaterials and additive manufacturing, enabling important compositional and microstructural features in surgical implants that promote healing, not otherwise commercially feasible.
Dimension Inx has partnered with renowned universities and hospitals, like Emory University, The Children’s Hospital of Philadelphia, Carnegie Mellon University, Nanyang Technological University in Singapore, and much more.
Dimension Inx has raised $3.175M in a Seed funding round on Nov 18, 2020. Backers included KdT Ventures, Better Ventures, and Revolution Ventures‘ investment fund Rise of the Rest Seed Fund.